Capture additional $27 for diagnostic following screening test. Watch for documentation: Because you must report the BPH codes to the fifth digit, you'll have to know whether the patient has a urinary obstruction that is symptomatic so you can select the proper code as follows: • 600.00 -- Hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptoms (LUTS) • 600.01 -- Hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (LUTS). Exception: CMS instructs coders to report 790.93 (Elevated prostate specific antigen [PSA]) when the test shows elevated PSA. Opportunity: If the physician provides a more specific diagnosis, however, choose an ICD-9 code that accurately reflects the patient's condition. For example, if the physician has established a diagnosis of prostate cancer, report the appropriate code, such as 185 (Malignant neoplasm of prostate) rather than elevated PSA (790.93). Don't Make This Cancer Mistake If the lab performs a PSA test (84153) following successful treatment for prostate cancer, you should not use the prostate cancer diagnosis code (185). Instead, report V10.46 (Personal history of malignant neoplasm; prostate). Mislabeling a patient as an active cancer patient could affect his ability to get health or life insurance or affect his treatment by other physicians for other conditions.